Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV13 in HIV Positive Adults
NCT02123433Phase 3Completed
- Sponsor
- Università di Siena
- Start
- Dec 2011
- Primary completion
- Oct 2013
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of pneumococcal 13-valent conjugate vaccine in pneumococcal infection, sponsored by Università di Siena. Started Dec 2011; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT02123433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02123433.